Loading…
Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation
Despite improvements in human leukocyte antigen matching and pharmacologic prophylaxis, acute graft-versus-host disease (GVHD) is often a fatal complication following hematopoietic stem cell transplant (HSCT). Older HSCT recipients experience significantly increased morbidity and mortality compared...
Saved in:
Published in: | PloS one 2013-09, Vol.8 (9), p.e75158-e75158 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c692t-a812f891780f17b806f26345be6dc71217c38846af9c9b4992c32d3b696edfe43 |
---|---|
cites | cdi_FETCH-LOGICAL-c692t-a812f891780f17b806f26345be6dc71217c38846af9c9b4992c32d3b696edfe43 |
container_end_page | e75158 |
container_issue | 9 |
container_start_page | e75158 |
container_title | PloS one |
container_volume | 8 |
creator | Scroggins, Sabrina M Olivier, Alicia K Meyerholz, David K Schlueter, Annette J |
description | Despite improvements in human leukocyte antigen matching and pharmacologic prophylaxis, acute graft-versus-host disease (GVHD) is often a fatal complication following hematopoietic stem cell transplant (HSCT). Older HSCT recipients experience significantly increased morbidity and mortality compared to young recipients. Prophylaxis with syngeneic regulatory dendritic cells (DCreg) in young bone marrow transplanted (BMT) mice has been shown to decrease GVHD-associated mortality. To evaluate this approach in older BMT recipients, young (3-4 months) and older (14-18 months) DCreg were generated using GM-CSF, IL-10, and TGFβ. Analysis of young versus older DCreg following culture revealed no differences in phenotype. The efficacy of DCreg treatment in older BMT mice was evaluated in a BALB/c→C57Bl/6 model of GVHD; on day 2 post-BMT (d +2), mice received syngeneic, age-matched DCreg. Although older DCreg-treated BMT mice showed decreased morbidity and mortality compared to untreated BMT mice (all of which died), there was a small but significant decrease in the survival of older DCreg-treated BMT mice (75% survival) compared to young DCreg-treated BMT mice (90% survival). To investigate differences between dendritic cells (DC) in young and older DCreg-treated BMT mice that may play a role in DCreg function in vivo, DC phenotypes were assessed following DCreg adoptive transfer. Transferred DCreg identified in older DCreg-treated BMT mice at d +3 showed significantly lower expression of PD-L1 and PIR B compared to DCreg from young DCreg-treated BMT mice. In addition, donor DC identified in d +21 DCreg-treated BMT mice displayed increased inhibitory molecule and decreased co-stimulatory molecule expression compared to d +3, suggesting induction of a regulatory phenotype on the donor DC. In conclusion, these data indicate DCreg treatment is effective in the modulation of GVHD in older BMT recipients and provide evidence for inhibitory pathways that DCreg and donor DC may utilize to induce and maintain tolerance to GVHD. |
doi_str_mv | 10.1371/journal.pone.0075158 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1431405038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478335282</galeid><doaj_id>oai_doaj_org_article_e8930dd18b48452bb9efa9cb75461e2e</doaj_id><sourcerecordid>A478335282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-a812f891780f17b806f26345be6dc71217c38846af9c9b4992c32d3b696edfe43</originalsourceid><addsrcrecordid>eNqNk1trFDEUxwdRbK1-A9EBQfRh19wmk7wIpXgpFAreXkMmczKbkp2sSaa1fhW_rNnutuxKH2QgE05-559zyamq5xjNMW3xu4swxVH7-SqMMEeobXAjHlSHWFIy4wTRhzv7g-pJShcINVRw_rg6IAwxRGV7WP05WeioTYbofuvswlgHW0cYJq9ziNd1D2MfXXamNuB9qvNC53pZDIPOUGszlXWI2ubZJcQ0pdkipFz3LoFOULsi53uIxcNAbYP34cqNQ63LZoARimxXwq-XOsZwVeeox7Tyesw3oTytHlntEzzb_o-q7x8_fDv5PDs7_3R6cnw2M1ySPNMCEyskbgWyuO0E4pZwypoOeG9aTHBrqBCMayuN7JiUxFDS045LDr0FRo-qlxvdlQ9JbeuaFGYUM9QgKgpxuiH6oC_UKroS8LUK2qkbQ4iD0rEUyYMCISnqeyw6JlhDuk6C1dJ0bcM4BgJF6_32tqlbQm9gLGn7PdH9k9Et1BAuFW15kaZF4M1WIIafE6Ssli6tu6NHCNNN3JS0mEtc0Ff_oPdnt6UGXRJwow3lXrMWVcesFZQ2RJBCze-hytdD6W7ponXFvufwds-hMBl-5UFPKanTr1_-nz3_sc--3mEXoH1epOCn9ZNJ-yDbgCaGlCLYuyJjpNYzdFsNtZ4htZ2h4vZit0F3TrdDQ_8CAoMaaw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1431405038</pqid></control><display><type>article</type><title>Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Scroggins, Sabrina M ; Olivier, Alicia K ; Meyerholz, David K ; Schlueter, Annette J</creator><contributor>Alici, Evren</contributor><creatorcontrib>Scroggins, Sabrina M ; Olivier, Alicia K ; Meyerholz, David K ; Schlueter, Annette J ; Alici, Evren</creatorcontrib><description>Despite improvements in human leukocyte antigen matching and pharmacologic prophylaxis, acute graft-versus-host disease (GVHD) is often a fatal complication following hematopoietic stem cell transplant (HSCT). Older HSCT recipients experience significantly increased morbidity and mortality compared to young recipients. Prophylaxis with syngeneic regulatory dendritic cells (DCreg) in young bone marrow transplanted (BMT) mice has been shown to decrease GVHD-associated mortality. To evaluate this approach in older BMT recipients, young (3-4 months) and older (14-18 months) DCreg were generated using GM-CSF, IL-10, and TGFβ. Analysis of young versus older DCreg following culture revealed no differences in phenotype. The efficacy of DCreg treatment in older BMT mice was evaluated in a BALB/c→C57Bl/6 model of GVHD; on day 2 post-BMT (d +2), mice received syngeneic, age-matched DCreg. Although older DCreg-treated BMT mice showed decreased morbidity and mortality compared to untreated BMT mice (all of which died), there was a small but significant decrease in the survival of older DCreg-treated BMT mice (75% survival) compared to young DCreg-treated BMT mice (90% survival). To investigate differences between dendritic cells (DC) in young and older DCreg-treated BMT mice that may play a role in DCreg function in vivo, DC phenotypes were assessed following DCreg adoptive transfer. Transferred DCreg identified in older DCreg-treated BMT mice at d +3 showed significantly lower expression of PD-L1 and PIR B compared to DCreg from young DCreg-treated BMT mice. In addition, donor DC identified in d +21 DCreg-treated BMT mice displayed increased inhibitory molecule and decreased co-stimulatory molecule expression compared to d +3, suggesting induction of a regulatory phenotype on the donor DC. In conclusion, these data indicate DCreg treatment is effective in the modulation of GVHD in older BMT recipients and provide evidence for inhibitory pathways that DCreg and donor DC may utilize to induce and maintain tolerance to GVHD.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0075158</identifier><identifier>PMID: 24040397</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acute Disease ; Adoptive Transfer ; Aging - immunology ; Aging - physiology ; Animals ; Antigens ; B7-H1 Antigen - metabolism ; Bone marrow ; Bone marrow transplantation ; Bone Marrow Transplantation - adverse effects ; Cell culture ; Cell survival ; Comparative analysis ; Cytokines ; Cytokines - biosynthesis ; Dendritic cells ; Dendritic Cells - immunology ; Disease ; Fatalities ; Gene Expression Regulation - immunology ; Graft vs Host Disease - etiology ; Graft vs Host Disease - immunology ; Graft vs Host Disease - metabolism ; Graft vs Host Disease - physiopathology ; Graft-versus-host reaction ; Granulocyte-macrophage colony-stimulating factor ; Health aspects ; Hematopoietic stem cell transplantation ; Hematopoietic stem cells ; Histocompatibility antigen HLA ; HLA antigens ; Humans ; Immune Tolerance ; Immunoglobulins ; Immunological tolerance ; Immunology ; Interdisciplinary aspects ; Interleukin 10 ; Laboratory animals ; Leukocytes ; Ligands ; Lymphocytes ; Medicine ; Mice ; Morbidity ; Mortality ; Pathology ; PD-L1 protein ; Pharmacology ; Phenotype ; Prophylaxis ; Receptors, Immunologic - metabolism ; Rodents ; Stem cell transplantation ; Stem cells ; Studies ; Survival ; Syngeneic grafts ; T cell receptors ; Time Factors ; Transforming growth factors ; Transplantation ; Transplantation, Homologous - adverse effects ; Transplants & implants</subject><ispartof>PloS one, 2013-09, Vol.8 (9), p.e75158-e75158</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 Scroggins et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 Scroggins et al 2013 Scroggins et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-a812f891780f17b806f26345be6dc71217c38846af9c9b4992c32d3b696edfe43</citedby><cites>FETCH-LOGICAL-c692t-a812f891780f17b806f26345be6dc71217c38846af9c9b4992c32d3b696edfe43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1431405038/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1431405038?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24040397$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Alici, Evren</contributor><creatorcontrib>Scroggins, Sabrina M</creatorcontrib><creatorcontrib>Olivier, Alicia K</creatorcontrib><creatorcontrib>Meyerholz, David K</creatorcontrib><creatorcontrib>Schlueter, Annette J</creatorcontrib><title>Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Despite improvements in human leukocyte antigen matching and pharmacologic prophylaxis, acute graft-versus-host disease (GVHD) is often a fatal complication following hematopoietic stem cell transplant (HSCT). Older HSCT recipients experience significantly increased morbidity and mortality compared to young recipients. Prophylaxis with syngeneic regulatory dendritic cells (DCreg) in young bone marrow transplanted (BMT) mice has been shown to decrease GVHD-associated mortality. To evaluate this approach in older BMT recipients, young (3-4 months) and older (14-18 months) DCreg were generated using GM-CSF, IL-10, and TGFβ. Analysis of young versus older DCreg following culture revealed no differences in phenotype. The efficacy of DCreg treatment in older BMT mice was evaluated in a BALB/c→C57Bl/6 model of GVHD; on day 2 post-BMT (d +2), mice received syngeneic, age-matched DCreg. Although older DCreg-treated BMT mice showed decreased morbidity and mortality compared to untreated BMT mice (all of which died), there was a small but significant decrease in the survival of older DCreg-treated BMT mice (75% survival) compared to young DCreg-treated BMT mice (90% survival). To investigate differences between dendritic cells (DC) in young and older DCreg-treated BMT mice that may play a role in DCreg function in vivo, DC phenotypes were assessed following DCreg adoptive transfer. Transferred DCreg identified in older DCreg-treated BMT mice at d +3 showed significantly lower expression of PD-L1 and PIR B compared to DCreg from young DCreg-treated BMT mice. In addition, donor DC identified in d +21 DCreg-treated BMT mice displayed increased inhibitory molecule and decreased co-stimulatory molecule expression compared to d +3, suggesting induction of a regulatory phenotype on the donor DC. In conclusion, these data indicate DCreg treatment is effective in the modulation of GVHD in older BMT recipients and provide evidence for inhibitory pathways that DCreg and donor DC may utilize to induce and maintain tolerance to GVHD.</description><subject>Acute Disease</subject><subject>Adoptive Transfer</subject><subject>Aging - immunology</subject><subject>Aging - physiology</subject><subject>Animals</subject><subject>Antigens</subject><subject>B7-H1 Antigen - metabolism</subject><subject>Bone marrow</subject><subject>Bone marrow transplantation</subject><subject>Bone Marrow Transplantation - adverse effects</subject><subject>Cell culture</subject><subject>Cell survival</subject><subject>Comparative analysis</subject><subject>Cytokines</subject><subject>Cytokines - biosynthesis</subject><subject>Dendritic cells</subject><subject>Dendritic Cells - immunology</subject><subject>Disease</subject><subject>Fatalities</subject><subject>Gene Expression Regulation - immunology</subject><subject>Graft vs Host Disease - etiology</subject><subject>Graft vs Host Disease - immunology</subject><subject>Graft vs Host Disease - metabolism</subject><subject>Graft vs Host Disease - physiopathology</subject><subject>Graft-versus-host reaction</subject><subject>Granulocyte-macrophage colony-stimulating factor</subject><subject>Health aspects</subject><subject>Hematopoietic stem cell transplantation</subject><subject>Hematopoietic stem cells</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA antigens</subject><subject>Humans</subject><subject>Immune Tolerance</subject><subject>Immunoglobulins</subject><subject>Immunological tolerance</subject><subject>Immunology</subject><subject>Interdisciplinary aspects</subject><subject>Interleukin 10</subject><subject>Laboratory animals</subject><subject>Leukocytes</subject><subject>Ligands</subject><subject>Lymphocytes</subject><subject>Medicine</subject><subject>Mice</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Pathology</subject><subject>PD-L1 protein</subject><subject>Pharmacology</subject><subject>Phenotype</subject><subject>Prophylaxis</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Rodents</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Studies</subject><subject>Survival</subject><subject>Syngeneic grafts</subject><subject>T cell receptors</subject><subject>Time Factors</subject><subject>Transforming growth factors</subject><subject>Transplantation</subject><subject>Transplantation, Homologous - adverse effects</subject><subject>Transplants & implants</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1trFDEUxwdRbK1-A9EBQfRh19wmk7wIpXgpFAreXkMmczKbkp2sSaa1fhW_rNnutuxKH2QgE05-559zyamq5xjNMW3xu4swxVH7-SqMMEeobXAjHlSHWFIy4wTRhzv7g-pJShcINVRw_rg6IAwxRGV7WP05WeioTYbofuvswlgHW0cYJq9ziNd1D2MfXXamNuB9qvNC53pZDIPOUGszlXWI2ubZJcQ0pdkipFz3LoFOULsi53uIxcNAbYP34cqNQ63LZoARimxXwq-XOsZwVeeox7Tyesw3oTytHlntEzzb_o-q7x8_fDv5PDs7_3R6cnw2M1ySPNMCEyskbgWyuO0E4pZwypoOeG9aTHBrqBCMayuN7JiUxFDS045LDr0FRo-qlxvdlQ9JbeuaFGYUM9QgKgpxuiH6oC_UKroS8LUK2qkbQ4iD0rEUyYMCISnqeyw6JlhDuk6C1dJ0bcM4BgJF6_32tqlbQm9gLGn7PdH9k9Et1BAuFW15kaZF4M1WIIafE6Ssli6tu6NHCNNN3JS0mEtc0Ff_oPdnt6UGXRJwow3lXrMWVcesFZQ2RJBCze-hytdD6W7ponXFvufwds-hMBl-5UFPKanTr1_-nz3_sc--3mEXoH1epOCn9ZNJ-yDbgCaGlCLYuyJjpNYzdFsNtZ4htZ2h4vZit0F3TrdDQ_8CAoMaaw</recordid><startdate>20130910</startdate><enddate>20130910</enddate><creator>Scroggins, Sabrina M</creator><creator>Olivier, Alicia K</creator><creator>Meyerholz, David K</creator><creator>Schlueter, Annette J</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20130910</creationdate><title>Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation</title><author>Scroggins, Sabrina M ; Olivier, Alicia K ; Meyerholz, David K ; Schlueter, Annette J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-a812f891780f17b806f26345be6dc71217c38846af9c9b4992c32d3b696edfe43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acute Disease</topic><topic>Adoptive Transfer</topic><topic>Aging - immunology</topic><topic>Aging - physiology</topic><topic>Animals</topic><topic>Antigens</topic><topic>B7-H1 Antigen - metabolism</topic><topic>Bone marrow</topic><topic>Bone marrow transplantation</topic><topic>Bone Marrow Transplantation - adverse effects</topic><topic>Cell culture</topic><topic>Cell survival</topic><topic>Comparative analysis</topic><topic>Cytokines</topic><topic>Cytokines - biosynthesis</topic><topic>Dendritic cells</topic><topic>Dendritic Cells - immunology</topic><topic>Disease</topic><topic>Fatalities</topic><topic>Gene Expression Regulation - immunology</topic><topic>Graft vs Host Disease - etiology</topic><topic>Graft vs Host Disease - immunology</topic><topic>Graft vs Host Disease - metabolism</topic><topic>Graft vs Host Disease - physiopathology</topic><topic>Graft-versus-host reaction</topic><topic>Granulocyte-macrophage colony-stimulating factor</topic><topic>Health aspects</topic><topic>Hematopoietic stem cell transplantation</topic><topic>Hematopoietic stem cells</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA antigens</topic><topic>Humans</topic><topic>Immune Tolerance</topic><topic>Immunoglobulins</topic><topic>Immunological tolerance</topic><topic>Immunology</topic><topic>Interdisciplinary aspects</topic><topic>Interleukin 10</topic><topic>Laboratory animals</topic><topic>Leukocytes</topic><topic>Ligands</topic><topic>Lymphocytes</topic><topic>Medicine</topic><topic>Mice</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Pathology</topic><topic>PD-L1 protein</topic><topic>Pharmacology</topic><topic>Phenotype</topic><topic>Prophylaxis</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Rodents</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Studies</topic><topic>Survival</topic><topic>Syngeneic grafts</topic><topic>T cell receptors</topic><topic>Time Factors</topic><topic>Transforming growth factors</topic><topic>Transplantation</topic><topic>Transplantation, Homologous - adverse effects</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scroggins, Sabrina M</creatorcontrib><creatorcontrib>Olivier, Alicia K</creatorcontrib><creatorcontrib>Meyerholz, David K</creatorcontrib><creatorcontrib>Schlueter, Annette J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints in Context (Gale)</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scroggins, Sabrina M</au><au>Olivier, Alicia K</au><au>Meyerholz, David K</au><au>Schlueter, Annette J</au><au>Alici, Evren</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-09-10</date><risdate>2013</risdate><volume>8</volume><issue>9</issue><spage>e75158</spage><epage>e75158</epage><pages>e75158-e75158</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Despite improvements in human leukocyte antigen matching and pharmacologic prophylaxis, acute graft-versus-host disease (GVHD) is often a fatal complication following hematopoietic stem cell transplant (HSCT). Older HSCT recipients experience significantly increased morbidity and mortality compared to young recipients. Prophylaxis with syngeneic regulatory dendritic cells (DCreg) in young bone marrow transplanted (BMT) mice has been shown to decrease GVHD-associated mortality. To evaluate this approach in older BMT recipients, young (3-4 months) and older (14-18 months) DCreg were generated using GM-CSF, IL-10, and TGFβ. Analysis of young versus older DCreg following culture revealed no differences in phenotype. The efficacy of DCreg treatment in older BMT mice was evaluated in a BALB/c→C57Bl/6 model of GVHD; on day 2 post-BMT (d +2), mice received syngeneic, age-matched DCreg. Although older DCreg-treated BMT mice showed decreased morbidity and mortality compared to untreated BMT mice (all of which died), there was a small but significant decrease in the survival of older DCreg-treated BMT mice (75% survival) compared to young DCreg-treated BMT mice (90% survival). To investigate differences between dendritic cells (DC) in young and older DCreg-treated BMT mice that may play a role in DCreg function in vivo, DC phenotypes were assessed following DCreg adoptive transfer. Transferred DCreg identified in older DCreg-treated BMT mice at d +3 showed significantly lower expression of PD-L1 and PIR B compared to DCreg from young DCreg-treated BMT mice. In addition, donor DC identified in d +21 DCreg-treated BMT mice displayed increased inhibitory molecule and decreased co-stimulatory molecule expression compared to d +3, suggesting induction of a regulatory phenotype on the donor DC. In conclusion, these data indicate DCreg treatment is effective in the modulation of GVHD in older BMT recipients and provide evidence for inhibitory pathways that DCreg and donor DC may utilize to induce and maintain tolerance to GVHD.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24040397</pmid><doi>10.1371/journal.pone.0075158</doi><tpages>e75158</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2013-09, Vol.8 (9), p.e75158-e75158 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1431405038 |
source | Publicly Available Content Database; PubMed Central |
subjects | Acute Disease Adoptive Transfer Aging - immunology Aging - physiology Animals Antigens B7-H1 Antigen - metabolism Bone marrow Bone marrow transplantation Bone Marrow Transplantation - adverse effects Cell culture Cell survival Comparative analysis Cytokines Cytokines - biosynthesis Dendritic cells Dendritic Cells - immunology Disease Fatalities Gene Expression Regulation - immunology Graft vs Host Disease - etiology Graft vs Host Disease - immunology Graft vs Host Disease - metabolism Graft vs Host Disease - physiopathology Graft-versus-host reaction Granulocyte-macrophage colony-stimulating factor Health aspects Hematopoietic stem cell transplantation Hematopoietic stem cells Histocompatibility antigen HLA HLA antigens Humans Immune Tolerance Immunoglobulins Immunological tolerance Immunology Interdisciplinary aspects Interleukin 10 Laboratory animals Leukocytes Ligands Lymphocytes Medicine Mice Morbidity Mortality Pathology PD-L1 protein Pharmacology Phenotype Prophylaxis Receptors, Immunologic - metabolism Rodents Stem cell transplantation Stem cells Studies Survival Syngeneic grafts T cell receptors Time Factors Transforming growth factors Transplantation Transplantation, Homologous - adverse effects Transplants & implants |
title | Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A19%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20regulatory%20dendritic%20cells%20that%20mitigate%20acute%20graft-versus-host%20disease%20in%20older%20mice%20following%20allogeneic%20bone%20marrow%20transplantation&rft.jtitle=PloS%20one&rft.au=Scroggins,%20Sabrina%20M&rft.date=2013-09-10&rft.volume=8&rft.issue=9&rft.spage=e75158&rft.epage=e75158&rft.pages=e75158-e75158&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0075158&rft_dat=%3Cgale_plos_%3EA478335282%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-a812f891780f17b806f26345be6dc71217c38846af9c9b4992c32d3b696edfe43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1431405038&rft_id=info:pmid/24040397&rft_galeid=A478335282&rfr_iscdi=true |